ライフサイエンスコーパス: ISA

1 ISA 720 appeared more effective than Freund's against oc

2 ISA functions were characterized in maize (Zea mays) lea

3 ISA is caused by the recessive Tyrp1b mutant allele and

4 ISA screening, carried out on the Prestwick Chemical Lib

5 ISA type proteins mediate cluster transfer to apoprotein

6 ISA uses all mass isotopomers, correctly identified impo

7 ISA was well tolerated in our ill patient population.

8 ISA>/=55% may thus serve as a predictor for long-term su

9 ISA-2011B significantly inhibits growth of tumor cells i

10 ISA-2011B was discovered during our synthetic studies of

11 ISA-2011B-treatment reduced expression of pSer-473 AKT (

12 received either 20 mug or 50 mug of ICC-1132/ISA 720 developed antiimmunogen and anti-HBc antibodies.

13 ripheral blood mononuclear cells of ICC-1132/ISA 720 vaccinees proliferated and released cytokines (i

14 -in-oil adjuvant Montanide ISA 720 (ICC-1132/ISA 720).

15 as similar among azoles (PCZ: 13%; VCZ: 15%; ISA: 13%).

16 ogether with KIO(3), 5-iodosalicylic acid (5-ISA) or 3,5-diiodosalicylic acid (3,5-diISA).

17 The use of 5-ISA allowed for achieving better efficiency of plant bio

18 P1(19) in a formulation of Montanide ISA 51 (ISA) plus CpG ODN 1826 was similar or superior to that c

19 (AIF)%, and Interstitial Space Abnormality (ISA)% demonstrated strong correlations with correspondin

20 partner violence, the Index of Spouse Abuse (ISA) and the Conflict Tactics Scale (CTS).

21 gnificant quantities of isosaccharinic acid (ISA), a chelating agent for radionuclides.

22 Late-acquired ISA has been reported in bare-metal stents (BMS) and bra

23 persistent ISA cases, whereas late-acquired ISA in SES occurred mostly in the mid portion of the ste

24 Late-acquired ISA was seen in the remaining seven cases, all from the

25 In late-acquired ISA, there was an increase in external elastic membrane

26 Infraslow activity (ISA) is a biomarker that has recently become of interest

27 anization of spontaneous infraslow activity (ISA) is plastic in that it can be modulated by learning

28 Acute ISA size (estimated as ISA volume or maximum ISA distanc

29 when appropriate to aim at minimizing acute ISA.

30 After 6 months, acute ISA volume decreased significantly, and 71.5% of the ISA

31 The larger the acute ISA, the greater the likelihood of persistent malapposit

32 characterize the vascular response to acute ISA in vivo and to look for predictors of incomplete hea

33 Segments with acute ISA had higher risk of delayed coverage than well-appose

34 Seventy-eight segments with acute ISA were identified in 36 of the patients and matched wi

35 In addition, ISA violations are commonly observed in tumor phylogenie

36 g used (second-line immunosuppressive agent [ISA] or biologicals), and drug doses were obtained.

37 ms, which we term isoform-selective alleles (ISAs).

38 Although ISA has been approved for treatment of invasive Aspergil

39 Immobilized sample amplification (ISA) is a novel method for amplification, detection, mon

40 An ISA assay of a 10-microl viral sample generates results

41 Malapposed segments with an ISA detachment <100 mum at baseline showed complete stru

42 uencing (SGS) and integration site analysis (ISA) provide useful information regarding the structure

43 sis (MIDA) and isotopomer spectral analysis (ISA) represent such methods and are based on the combina

44 calculated by isotopomer spectral analysis (ISA), a nonlinear regression method, did not agree with

45 tly parallels independent subspace analysis (ISA) with the only difference that SSA maximizes slownes

46 n NIDDM vs. IDDM at baseline, P = 0.001, and ISA were greater in IDDM vs. NIDDM at 6 months, P = 0.00

47 We hypothesize that IPD and ISA alter melanosomes, allowing toxic intermediates of p

48 This is supported by the rescue of IPD and ISA in D2 eyes with substantially decreased pigment prod

49 nctional genetic tests, we show that IPD and ISA result from mutations in related genes encoding mela

50 re (MOR) and compression strength of ISB and ISA wood specimens were both increased.

51 However, memISA and ISA can add extra high-quality clusters to the set produ

52 chments only slightly exceeded by memISA and ISA.

53 rate, ca. 10 samplesh(-1), mobile phase and ISA solution consumption, ca. 2.6 mL per analysis, and C

54 tween the filter shapes learned with SSA and ISA.

55 the presence of insulin-specific antibodies (ISA), insulin lispro-specific antibodies (LSA), and cros

56 ented inflammation-associated self-antigens (ISA).

57 ns (TRAs), inflammation-associated antigens (ISAs), and peripheral antigens imported via circulation

58 no negative clinical events reported for any ISA cases at 12-month clinical follow-up.

59 Incomplete stent apposition (ISA) has been observed frequently in patients with very

60 he frequency of incomplete stent apposition (ISA) in sirolimus-eluting stents (SES) and clarify its f

61 Incomplete stent apposition (ISA) is characterized by the lack of contact of at least

62 action to acute incomplete stent apposition (ISA) is not well known.

63 ed with an independent system approximation (ISA), including proteins.

64 ze of the left atrial isolated surface area (ISA) after pulmonary vein antrum isolation for paroxysma

65 ss; Landsat-derived impervious surface area (ISA); and Visible Infrared Imaging Radiometer Suite (VII

66 Research, Bangladesh [icddr,b] service area [ISA] and government service area [GSA]) of the Matlab He

67 rapid expansion of impervious surface areas (ISA) threatens soil organic carbon (SOC) pools in urbani

68 alpha exerts similar effects on PC3 cells as ISA-2011B treatment, significantly inhibiting AKT activi

69 Acute ISA size (estimated as ISA volume or maximum ISA distance per strut) was an ind

70 ce (SPR)-based inhibition in solution assay (ISA) to search for inhibitors of the medium affinity (KD

71 n the multi-omics Investigation/Study/Assay (ISA-Tab) format and can be queried in the data repositor

72 based on the "inhibition in solution assay" (ISA) approach using an immobilized target definition com

73 Inhibition-in-solution assays (ISA) employing surface-based biosensors such as surface

74 s through spontaneous in situ self-assembly (ISA).

75 ee satisfying the infinite sites assumption (ISA).

76 t dispersion (IPD) and iris stromal atrophy (ISA).

77 loped by the International Seabed Authority (ISA)(1); however, a lack of experimental data has so far

78 lated by the International Seabed Authority (ISA).

79 The average ISA for all patients was 59.2+/-11.6%.

80 rface-bound partner is optimal for SPR-based ISA screening.

81 BLI-ISA meets or exceeds the performance of high complexity

82 ayer interferometry immunosorbent assay (BLI-ISA) utilizes single-use biosensors in an automated "dip

83 In a broader sense, BLI-ISA can be developed as a novel diagnostic platform to e

84 istributions of the samples were analyzed by ISA and the two-isotopomer method to determine whether e

85 was found to be similar for native and C136A ISA, with an observed pK(a) of 7.8 determined from the p

86 roximately -38.9 cal K(-1) mol(-1) for C136A ISA).

87 reaction for the wild type versus this C136A ISA derivative is distinct (DeltaH* approximately 6.3 kc

88 ene is a candidate for isa and likely causes ISA via a mechanism involving pigment production.

89 Biochemical analyses characterized ISA activities in mutant tissues.

90 (1->6)-glucosidases of the isoamylase class (ISA).

91 can be achieved after switching or combining ISAs.

92 igh potential as a drug target, and compound ISA-2011B is interesting for further development of targ

93 able target for our newly developed compound ISA-2011B using a high-throughput KINOMEscan platform.

94 imilar to the far field of a GDF, containing ISA as the sole carbon source, and elevated phosphate co

95 ace configuration of the copper site in S-Cu-ISA/SNC is detected to be an unsymmetrically arranged Cu

96 k derived hierarchically porous carbon (S-Cu-ISA/SNC).

97 ritic subthreshold A-type potassium current (ISA) channels.

98 Subthreshold A-type K(+) currents (ISA s) have been recorded from the cell bodies of hippoc

99 Subthreshold A-type K(+) currents (ISA s) have been recorded from the somata of nociceptors

100 Concentration-dependent ISA, carried out on a subset of 19 potential inhibitors,

101 d strut malapposed with moderate detachment (ISA detachment distance <100 mum) have minimal disturban

102 luate their transcriptomic regulation during ISA virus (ISAV) infection, an Orthomyxoviridae virus as

103 f isoamylase-type starch-debranching enzyme (ISA) proteins and complexes in maize (Zea mays) endosper

104 Isoamylase-type starch debranching enzymes (ISA) play important roles in starch biosynthesis in chlo

105 isoamylase-type starch debranching enzymes (ISAs), including the catalytic ISA1 and noncatalytic ISA

106 ab and Isatuximab (Fab'(DARA)-MORF1 and Fab'(ISA)-MORF1) targeted CD38.

107 s yielded an optimal cutoff value of 55% for ISA.

108 was 2.9% for PCZ, 4.8% for VCZ, and 5.7% for ISA (P = .55).

109 nd bulk sequencing data while accounting for ISA violating mutations.

110 its that associate with Kv4 subunits to form ISA channels in vivo.

111 hon packages that can automatically generate ISA-Tab metadata file stubs from raw XML metabolomics da

112 Greenness, ISA, and NTL were associated with increased SBP, DBP, an

113 form iodic sulfuric anhydride (IO(3)SO(3)H, ISA) and disulfuric acid (H(2)S(2)O(7), DSA).

114 nts had LSA (0-4%) and approximately 10% had ISA, whereas 41-45% of patients with IDDM and 23-27% of

115 Among these, 12 had ISA after intervention and at follow-up (persistent ISA)

116 ne with ISA1 homomer but lacking heteromeric ISA and a second line with one form of ISA1/ISA2 heterom

117 Thus, a function of heteromeric ISA not compensated for by homomeric enzyme affects gran

118 icating that either homomeric or heteromeric ISA is competent for starch biosynthesis.

119 Residing in areas with higher ISA or NTL, or lower greenness, was significantly associ

120 g distinct binding sites for binding of holo ISA and ISU to apo Fd.

121 incidence of FLHS of 150 individually housed ISA Brown hens ranked on the basis of feed conversion ra

122 tence of Kv4/KChIP/DPPL ternary complexes in ISA -expressing nociceptors and pain-modulating spinal i

123 nd dicots is responsible for distinctions in ISA function.

124 ed with 5gP DNA or 5gP protein emulsified in ISA 720 or Freund's adjuvant.

125 e pooled, inconsistent changes were noted in ISA and LSA (LSA were greater in NIDDM vs. IDDM at basel

126 ing instrument and acquisition parameters in ISA-Tab format on users, who have to do it manually, a p

127 Emulsification of the 5gP protein in ISA 720 appeared to be more effective than emulsificatio

128 nificant differences were noted over time in ISA, LSA, or CRA attributable to the type of short-actin

129 dure and to vascular healing might influence ISA occurrence.

130 nhibition of PIP5K1alpha using its inhibitor ISA-2011B, or via knockdown suppressed growth and invasi

131 debranching enzyme activity present is ISA1/ISA heteromer.

132 Isavuconazole (ISA) and voriconazole (VORI) are recommended as the firs

133 Isavuconazole (ISA) is an attractive candidate for primary mold-active

134 Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised pati

135 (PCZ), voriconazole (VCZ), or isavuconazole (ISA) for > 5 days as PAP during RIC were included.

136 debranching enzyme ISOAMYLASE1-ISOAMYLASE2 (ISA; to alter branching pattern).

137 After 12 months, a larger ISA was associated with a significantly lower AF and mac

138 Late ISA was observed in 8.7% of patients after SES implantat

139 However, the characteristics of late ISA in SES have not been clarified.

140 l histopathology and clinical studies linked ISA to stent thrombosis, potential selection bias preclu

141 tic mobility of recombinant and native maize ISA differed, suggestive of posttranslational modificati

142 tely seizure-related low frequencies, making ISA difficult to study in clinical EEG recordings.

143 ndosperm contained three high molecular mass ISA complexes resolved by gel permeation chromatography

144 t follow-up, whereas segments with a maximal ISA detachment distance of 100 to 300 mum and >300 mum h

145 ISA size (estimated as ISA volume or maximum ISA distance per strut) was an independent predictor of

146 icle-treated controls = 2160 mm(3), and mean ISA-2011B-treated = 600 mm(3), p < 0.001).

147 aper, four clustering methods, CRC, k-means, ISA and memISA, are used upon three brain expression dat

148 explored a microscopy-based single-molecule ISA compatible with liposome-reconstituted membrane prot

149 formulated in the Seppic adjuvant Montanide ISA 206 VG.

150 yrosinase emulsified with adjuvant Montanide ISA 51 and received a fully human anti-cytotoxic T-lymph

151 more potent water-in-oil adjuvant Montanide ISA 720 (ICC-1132/ISA 720).

152 , 200 nmol of AGS-v with adjuvant (Montanide ISA 51), or sterile water as placebo.

153 with incomplete Freund's adjuvant (Montanide ISA 51; Seppic SA, Paris, France).

154 plus incomplete Freund's adjuvant (Montanide ISA-51) once per cycle, followed by interleukin-2.

155 strain Nigg II using CpG-1826 and Montanide ISA 720 VG as adjuvants.

156 CpG-1826 and Montanide ISA 720 were used as adjuvants.

157 P) plus the adjuvants CpG-1826 and Montanide ISA 720; then they were challenged with C. muridarum.

158 ny-stimulating factor (GM-CSF) and Montanide ISA-51 adjuvant (Seppic Inc, Fairfield, NJ), or pulsed o

159 with HIV Gag protein emulsified in Montanide ISA 51, an oil-based adjuvant, with or without a TLR7/8

160 yoelii (rPyCSP), when delivered in Montanide ISA 51, induced sterilizing immunity against sporozoite

161 are immunization of 5gP protein in Montanide ISA 720 (SEPPIC, Paris, France), an adjuvant recently ap

162 gle dose of ICC-1132 formulated in Montanide ISA 720 encourage further clinical development of this m

163 d rabbits and mice with LSA-NRC in Montanide ISA 720.

164 c when administered with GM-CSF in Montanide ISA-51 adjuvant.

165 xM (500 mug once every 2 weeks) in Montanide ISA-51 plus sargramostim (granulocyte macrophage colony-

166 th recombinant Pfs25 formulated in Montanide ISA-720 increased antibody titers (30-fold) and signific

167 d by yMSP1(19) in a formulation of Montanide ISA 51 (ISA) plus CpG ODN 1826 was similar or superior t

168 with recombinant NY-ESO-1 protein, Montanide ISA-51, and CpG ODN 7909, a potent stimulator of B cells

169 ter membrane protein (MOMP), using Montanide ISA 720 and CpG-1826 as adjuvants.

170 uvanted with either Quil A or with Montanide ISA 720 plus CpG oligodeoxynucleotide (ODN) and was obse

171 L. major SEAgs coadministered with Montanide ISA 720.

172 eptide epitopes were emulsified in Montanide-ISA-51 and given every 3 weeks with intramuscular polyin

173 afficking and reconstituting native neuronal ISA-like properties.

174 </=10 mg and sustained control) with the new ISA.

175 In addition, bIFIs complicated 10.2% of ISA, 4.1% of POS, and 1.1% of VOR courses among patients

176 ary aspergillosis (IPA) complicating 6.8% of ISA, 1.3% of POS, and zero VOR courses.

177 Despite theoretical advantages of ISA, both triazole agents have not been compared in soli

178 arily in the converted croplands) because of ISA expansion from 1990 to 2010.

179 and shear distribution in different cases of ISA with increasing strut-wall detachment distance (rang

180 forty-five patients received 197 courses of ISA prophylaxis.

181 Coverage of ISA segments is delayed with respect to well-apposed seg

182 and HCT recipients who received >=7 days of ISA primary prophylaxis between 1 September 2016 and 30

183 urses, after a median duration of 14 days of ISA prophylaxis.

184 Although microbial degradation of ISA has been demonstrated, its impact upon the fate of r

185 evaluate the impact of different degrees of ISA severity on abnormal shear rate and healing response

186 riod visual experience on the development of ISA correlation and latency patterns within and across c

187 The accurate diagnosis of ISA, initially only possible with intravascular ultrasou

188 patterns of SOCISA and mapped the impact of ISA expansion on SOC storage.

189 ability to assess the ecological impacts of ISA expansion.

190 with Kv4 and KChIP at the plasma membrane of ISA -expressing neuron somata supports the existence of

191 matologic malignancy receiving >=6 months of ISA.

192 g) could ultimately reduce the occurrence of ISA and its potentially harmful consequences.

193 ed, or bare, depending on the persistence of ISA and on the coverage.

194 e per strut) was an independent predictor of ISA persistence and of delayed healing at follow-up.

195 VUS images were reviewed for the presence of ISA.

196 ic zone may be identified by the presence of ISA.

197 Substitution of the cysteine residues of ISA produced derivative proteins (C72A, C136A, and C138A

198 d for further study to determine the role of ISA as primary prophylaxis.

199 ing stent implantation, suggesting a role of ISA in the pathogenesis of this adverse event.

200 nt or absent) and to define the threshold of ISA detachment that might benefit from optimization duri

201 However, data supporting the use of ISA for primary prophylaxis in these patients are lackin

202 very low density lipoprotein by a variant of ISA designed to detect gradients in precursor enrichment

203 A combination of ISAs were used in 53 episodes, with "success" being achi

204 ty-five episodes involved switching from one ISA to another, with 50% to 100% of these patients achie

205 g clusters produced by k-means and memISA or ISA leads to increased GO enrichment and number of clust

206 gle time point assessments comparing overall ISA percentage and magnitude in different groups (i.e.,

207 s primarily at the stent edges in persistent ISA cases, whereas late-acquired ISA in SES occurred mos

208 er intervention and at follow-up (persistent ISA).

209 ) develop an iris stromal atrophy phenotype (ISA).

210 lusion of CpG ODN 1826 in the yMSP1(19) plus ISA vaccine contributed towards the induction of higher

211 ster transfer from Schizosaccharomyces pombe ISA to apo Fd.

212 We present here a novel quantitative ISA assay for retroviruses using a replication-defective

213 The format and protocol of this quantitative ISA assay can be easily automated to fit into numerous p

214 The incidence of bIFIs in patients receiving ISA was compared to those receiving posaconazole (POS) a

215 Neointimal healing tends to reduce ISA, with the malapposed stent struts often integrated c

216 osynthesis were tested, and GBSS, SS, SBEII, ISA, and AGPase were highly expressed in TNN18 and TNG31

217 l-dipeptide as adjuvant emulsified in SEPPIC ISA 720.

218 ith floating strut that has more significant ISA distance.

219 y be a critical component of somatodendritic ISA channels in the brain.

220 nels are responsible for the somatodendritic ISA s.

221 ights repository, powered by the open source ISA framework, is cross-species and cross-technique.

222 tical for promoting cluster transfer from Sp ISA (at 25 degrees C, k(2) approximately 170 M(-1) min(-

223 in mice to examine whole-cortex spontaneous ISA patterns.

224 rience induces global changes in spontaneous ISA relationships, both within the visual network and ac

225 experiments can be exported in the standard ISA-Tab format for deposition in public databases.

226 cuss how this method can be applied to study ISA to identify and assess the seizure onset zone.

227 Subgroup analysis showed that ISA was 42.8+/-4.2% in group I (n=23), 54.2+/-3.0% in gr

228 The ISA analyses of MIDs of fatty acids and sterols from liv

229 The ISA was defined as the ratio of the total isolated antra

230 rate of 12-wk clinical response between the ISA and VORI groups (59.6% versus 59.7%, respectively; o

231 For the ISA and CTS, the prevalence rates were 24.3% (95% CI, 19

232 Minor variations in rate constant for the ISA Cys derivatives do not reflect any change in the aff

233 Patients in the ISA group were less likely to experience treatment-emerg

234 The morphological pattern of healing in the ISA segments was categorized as homogeneous, layered, cr

235 ard trend in RV+ diarrheal incidences in the ISA villages during 3.5 years of routine HRV use, though

236 In the ISA-fermentation experiment, U(VI) was precipitated as i

237 antibody following a single injection of the ISA 720 formulated vaccine were comparable to those obta

238 u1 physical interacts with components of the ISA [4Fe-4S] assembly complex and client proteins that n

239 stallization is determined by aspects of the ISA complexes beyond enzymatic activity.

240 The impacts of the ISA expansion varied spatially, depending on the land- u

241 me decreased significantly, and 71.5% of the ISA segments were completely integrated into the vessel

242 component chromophores, the validity of the ISA should never be taken for granted and the effective

243 ic tool that may serve as a component of the ISA software suite.

244 Since the ISA method eliminates the isolation/extraction of the nu

245 f the matrix method, we demonstrate that the ISA is not valid for the title compound.

246 ive values of the PVS were compared with the ISA and the CTS as criterion standards.

247 Compared with the ISA, the sensitivity of the PVS in detecting partner abu

248 P and DPPL are coexpressed with Kv4 in these ISA -expressing pain-related neurons is unknown.

249 Three ISA activity forms were observed in leaves, two ISA1/ISA

250 ent with the protein compositions, all three ISA complexes were missing in an ISA1-null line, whereas

251 ents were divided into 4 groups according to ISA (group I: <50%; group II: 50 to <60%; group III: 60

252 ormal starch characteristics, in contrast to ISA-null lines, indicating that either homomeric or hete

253 chronic total occlusions might predispose to ISA.

254 Most were similarly regulated in response to ISA virus infection; (ii) The transcript subsets were un

255 at treatment (ISB) and after heat treatment (ISA).

256 e paucity of field observations on SOC under ISA (SOCISA), especially in dryland areas has limited ou

257 n increased rate of bIFI, notably IPA, using ISA for primary prophylaxis.

258 ls, and the number of mutations that violate ISA (real or because of incorrect copy number estimation

259 d an important impact of baseline strut-wall ISA distance on the risk of incomplete strut coverage at

260 as 10 microl, is almost impossible, whereas ISA assay detects retroviruses from as small as 1 to 5 m

261 unized with yMSP1(19), 22 of 32 (68.7%) with ISA plus CpG 1826, 0 of 4 (0%) with CFA/incomplete Freun

262 18), octadecyl-modified SVs) adjuvanted with ISA 206 VG primed strong Ab and T cell responses to p67C

263 robable IA that were treated for >=48 h with ISA (n = 57) or VORI (n = 77) as first-line therapy, eit

264 of delayed strut coverage both increase with ISA detachment distance.

265 juvant, 0 of 4 (0%) with CpG 1826 mixed with ISA (no yMSP1(19)), and 0 of 11 (0%) with CpG 1826 alone

266 Front-line treatment with ISA for posttransplant IA led to similar clinical outcom